Login
$EEIQ
$4.40 -$0.06 (1.42%) Close

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q4 FY2025
As of Sep 30, 2025
Q4 FY2024
As of Sep 30, 2024
Q4 FY2023
As of Sep 30, 2023
Q4 FY2022
As of Sep 30, 2022
Q4 FY2021
As of Sep 30, 2021
Current Assets
Cash and cash equivalents
Restricted cash
Accounts receivable, net
Accounts receivable, net of credit loss allowance of $nil and $nil
Other receivable
Prepaid expenses
Other prepaid for events
Inventory
Notes receivable
Income tax receivable
Total current assets
Non-current assets
Property and equipment, net
Long-term prepaids
Intangible assets
Right-of-use assets
Goodwill
Total assets
Current liabilities
Accounts payable and other liabilities
Loan payable
Income tax payable
Due to related party
Lease liabilities – current
Deferred revenue
Total current liabilities
Non-current liabilities
Loan payable
Lease liabilities – non current
Deferred income tax liabilities
Total liabilities
Shareholders’ equity
Common shares, US$0.0015873 par value, 970,000,000 ordinary shares and 10,000,000 preferred shares authorized, 23,396,667 and 13,113,173 ordinary shares issued and outstanding as of September 30, 2025 and 2024, respectively
Additional paid-in capital
Deficit
Accumulated other comprehensive loss
Total shareholders’ equity
Non-controlling interests
Total liabilities and shareholders’ equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support